Anti-CSN4 antibody [EPR7453]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(2 Publications)
Rabbit Recombinant Monoclonal CSN4 antibody. Suitable for WB and reacts with Human samples. Cited in 2 publications.
View Alternative Names
CSN4, COPS4, COP9 signalosome complex subunit 4, SGN4, Signalosome subunit 4, JAB1-containing signalosome subunit 4
- WB
Unknown
Western blot - Anti-CSN4 antibody [EPR7453] (AB139688)
All lanes:
Western blot - Anti-CSN4 antibody [EPR7453] (ab139688) at 1/1000 dilution
Lane 1:
SH-SY5Y cell lysate at 10 µg
Lane 2:
HepG2 cell lysate at 10 µg
Lane 3:
HeLa cell lysate at 10 µg
Lane 4:
PC3 cell lysate at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 46 kDa
false
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Cell death and differentiation 28:780-798 PubMed32968199
2020
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 9:e90054 PubMed24608665
2014
Applications
WB
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com